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Abstract
A general method is presented for patient-specific 3-dimensional absorbed dose calculations based
on quantitative SPECT activity measurements.
Methods—The computational scheme includes a method for registration of the CT image to the
SPECT image and position-dependent compensation for attenuation, scatter, and collimator detector
response performed as part of an iterative reconstruction method. A method for conversion of the
measured activity distribution to a 3-dimensional absorbed dose distribution, based on the EGS4
(electron-gamma shower, version 4) Monte Carlo code, is also included. The accuracy of the activity
quantification and the absorbed dose calculation is evaluated on the basis of realistic Monte Carlo–
simulated SPECT data, using the SIMIND (simulation of imaging nuclear detectors) program and a
voxel-based computer phantom. CT images are obtained from the computer phantom, and realistic
patient movements are added relative to the SPECT image. The SPECT-based activity concentration
and absorbed dose distributions are compared with the true ones.
Results—Correction could be made for object scatter, photon attenuation, and scatter penetration
in the collimator. However, inaccuracies were imposed by the limited spatial resolution of the SPECT
system, for which the collimator response correction did not fully compensate.
Conclusion—The presented method includes compensation for most parameters degrading the
quantitative image information. The compensation methods are based on physical models and
therefore are generally applicable to other radionuclides. The proposed evaluation methodology may
be used as a basis for future intercomparison of different methods.
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Radionuclide therapy (RNT) requires accurate determination of absorbed dose so that
fundamental dose–response relationships can be established and the efficacy and toxicity of
treatments assessed. Accurate calculation of absorbed dose in RNT is challenging because the
in vivo activity distribution, that is, the radiation source, initially is unknown in both space and
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time and is subject to change. In comparison with external-beam therapy, dose planning in
RNT is therefore more difficult. For RNT, measurement of the distribution of activity in 3
dimensions is important, to enable a determination of the position-dependent distribution of
the absorbed dose. In a recent review article, Zanzonico (1) discussed the importance of the
spatial heterogeneity of absorbed dose at a macroscopic level and stated that nonuniformity of
tumor absorbed dose might make it difficult to reliably predict therapeutic response in RNT.
When the absorbed dose to a volume of interest (VOI) is represented with an average value,
absorbed doses to subregions within the VOI, and perhaps having values higher or lower than
the average, will be undetermined (2). In most radionuclide therapies (and especially for
radioimmunotherapy), the activity concentration is low for tumor tissue. The outcome of a
therapy is then limited by the normal tissue toxicity. For maximization of the absorbed dose
to malignant tissue, the activity concentration in and absorbed dose to normal tissues must
therefore be determined with a high accuracy.
The combination of suitable photons for scintillation camera imaging and medium-ranged β-
particles for therapy makes 131I versatile for many RNT treatment protocols. In RNT, SPECT
is superior to planar imaging because of an ability to image the activity distribution in 3
dimensions. The accuracy of SPECT quantification is, however, affected by many factors,
which include attenuation, scatter, and finite spatial resolution. The latter is a major concern
in 131I SPECT because, typically, collimators optimized for higher-energy isotopes have poor
spatial resolution. In addition, collimator septal penetration by the high-energy emissions
of 131I (364, 637, and 723 keV) has been recognized as one of the principal limitations to
accurate SPECT imaging and quantification. Despite the low abundance of the highly
penetrating 637- and 723-keV photons, their contribution has been shown to be significant
(3). Energy-spectrum–based correction methods, such as the triple-energy-window method,
provide a reasonable correction for 131I scatter but do not adequately correct for collimator
penetration (3). Tumor and organ activity quantification is affected by the spread, or blurring,
of local counts to surrounding areas because of the finite spatial resolution of the system and
septal penetration. The spill-out of counts from the target to the background decreases the tumor
activity estimate as the source structure gets smaller, whereas the spill-in contribution from the
background to the target increases the tumor activity estimate. In a previous Monte Carlo study,
we showed the significance of spill-out and spill-in on 131I tumor activity quantification (4).
In an attempt to improve the accuracy of 131I quantification in the current study, we include
collimator detector response (CDR) compensation in the iterative reconstruction algorithm.
The CDR includes both the geometric and the penetration components.
The aim of this article is 3-fold. First, we present a quantification methodology for 131I SPECT
that includes a method for registration of CT and SPECT images and position-dependent
compensation for attenuation, scatter, CDR, and collimator septal penetration, performed as
part of an iterative reconstruction method. Second, a method for calculation of the absorbed
dose distribution in 3 dimensions, based on the EGS4 (electron-gamma shower, version 4)
Monte Carlo code, is presented. This method accurately accounts for density and atomic
number variations in tissue by direct electron- and photon-transport calculations and scoring
of the energy depositions from each particle in a voxel-based representation of the patient (5–
7). Third, an extensive evaluation outlines a new methodology for quality control of correction
methods performed in association with absorbed dose calculations. This evaluation uses images
obtained from Monte Carlo simulations and a patientlike computer phantom. An important
advantage of using Monte Carlo–generated data is the ability of the data to simulate idealized
cases without, for example, scatter and attenuation, enabling detailed investigations of the
respective sources of inaccuracy.
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The principle behind the presented quantification methodology is as follows. The patient
undergoes sequentially both SPECT and CT acquisitions. A preliminary SPECT image is
reconstructed, to which the CT image is registered. The CT image is converted to an image of
the mass density through application of a calibration-based relationship (8). The CT image is
also converted to a map of the linear attenuation coefficients at 364 keV through multiplication
of each density voxel value by values of the mass attenuation coefficients for either water
(0.1102 g/cm−2) or bone (0.1116 g/cm−2), each separated at a threshold of density 1.2 g/
cm−3. The mass attenuation coefficient for air (≈78% N2 and 18% O2) is approximately 10%
lower than the water coefficient at 364 keV, so the water mass attenuation coefficient has been
used also in the lung region. The dataset undergoes a full reconstruction, in which the linear
attenuation map is used for position-dependent attenuation correction and for scatter or
penetration compensation. Counting rate is converted to activity by application of a single
calibration factor (cps/MBq) measured in air. The activity image and the mass density image
are then read by a program that calculates the absorbed dose in 3 dimensions. For analysis of
the absorbed dose in VOIs, segmentation is performed on data from the CT image, the activity
image, or the absorbed dose image.
Image Registration
CT and SPECT images are registered through application of both a patient positioning
procedure and, subsequently, a registration program. Positioning consists of using a flat and
similarly shaped couch for both the CT and the SPECT acquisitions and applying cocalibrated
directional lasers for both instruments (9). The registration program uses the mutual
information as a similarity measure (10). The CT and SPECT images normally have a differing
axial field of view, sometimes truncated in relation to each other. The normalized mutual
information is applied for all registrations in this study to avoid alignment of the edges of the
field of view, rather than of the internal structures, by the registration algorithm (11).
Furthermore, an option has been included to calculate the similarity measure on a restricted
part of the image, for cases in which some part, for example, the legs, is of minor interest and
therefore is not desired to influence the registration.
The registration procedure starts by rescaling the voxel size of the CT image to that of the
SPECT image, according to the pixel sizes and slice thicknesses stated in the image header.
An initial prematch is then performed by a rough determination of 3-dimensional (3D)
translations. The rough axial translation is estimated by coaligning a manually selected
homologous position. In-plane translations are estimated from the maximal cross-correlation,
calculated in the frequency domain using a 3D Fourier transformation. A 6-parameter
optimization is then performed, in which the optimal values of translations and rotations in 3
orthogonal directions are determined. Trilinear interpolation is applied throughout, and
optimization is performed using Powell’s method (12).
The current application involves SPECT images acquired in radioimmunoimaging for
diagnosis or therapy. Such images generally have modest quality and present few anatomic
details. In the absence of anatomically detailed photopeak images, Compton scatter images are
used, which better identify the patient contour and thereby provide useful registration features.
The scatter images are acquired simultaneously with the photopeak images in an additional
energy window located at 32–132 keV. The width and location of the scatter window are
selected with respect to the intensity of large-angle multiple-scattered photons, which are
considered likely to represent peripheral parts of the body. The scatter SPECT image is
reconstructed, and the CT study is registered to it. Because the photopeak and the scatter SPECT
studies are acquired simultaneously, this process brings the photopeak and the CT studies into
geometric correspondence.
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Image Reconstruction, Attenuation, and Scatter Compensation
SPECT images are reconstructed using an iterative ordered-subsets expectation maximization
algorithm, which includes compensation for nonuniform attenuation, scatter, and CDR. Photon
attenuation is modeled on the basis of an attenuation map obtained from the CT image.
Scatter compensation is performed by modeling the spatially variant object-dependent scatter
response in a projector using the effective source scatter estimation (ESSE) model (13,14). In
this model, the 3D activity estimate is resampled into planes in the image grid that are parallel
to the collimator face. An effective scatter source is estimated and added to the activity estimate.
The attenuated projection of this effective scatter source provides an estimate of the scatter
component of the projection data. The estimation of the effective scatter source uses 2
precalculated scatter kernels. These kernels depend on the isotope, energy window, and pixel
size but are independent of the object being imaged and thus do not need to be calculated for
each patient. In this study, they are calculated using the SIMIND (simulation of imaging nuclear
detectors) Monte Carlo code (15). The scatter estimation involves three 3D Fourier transforms
and some pixel-by-pixel operations for each projection view and requires much less time than
the CDR modeling discussed below. The ESSE scatter model has been extensively validated
for 99mTc and 201Tl (14).
CDR Compensation
Modeling the spatially varying septal penetration component of the CDR during the projection
step described above compensates for the geometric and septal penetration response. The CDR
(including penetration and geometric components) is estimated using a modified version of the
MCNP-4B Monte Carlo simulation code. The modeling is performed by generating a table of
CDRs as a function of distance from the face of the collimator. The spacing of the CDRs in
this table is equal to the image pixel size. Monte Carlo simulations of a point source in air,
located at various distances from the collimator, are performed. The response function is
averaged in the direction parallel to the surface of the collimator so that the resulting CDR is
spatially invariant for a certain source–collimator distance.
It is essential to have low-noise CDRs for compensation. However, computing the CDR to a
low noise level requires simulating a large number of photons (~10 billion). To reduce the
computational burden, a very-low-noise CDR is simulated for 1 source distance, in this case
10 cm from the face of the collimator. The CDRs for other distances are then estimated by
scaling the size of this CDR. The scaling factors are estimated through simulation of CDRs of
1 billion photons at source-to-collimator distances of 1, 5, 20, 30, 40, and 50 cm. From these,
the full width at half maximum (FWHM) of the geometric portion of the response is calculated.
In addition, the scale factors for intermediate distances is determined by linear interpolation
between the above points. To obtain the CDR at any particular distance, the size-scaling factor
is calculated as the ratio of the FWHM of the geometric response at the distance of interest
divided by the FWHM of the geometric response at 10 cm.
The CDR for each distance should be normalized so that its sum is equal to the primary-to-
total ratio (PTR). The PTR depends on distance in a complex way, especially at distances close
to the collimator. In addition, PTR can be estimated with good accuracy using a smaller number
of photons than is needed to estimate the FWHM. Thus, 500 million photons at distances of 0,
2, 3, 4, 6, 7, 8, and 9 cm are simulated. From the PTRs and the previous distances, the
intermediate PTRs are estimated using bilinear interpolation.
In the projector modeling, the CDR is implemented using a rotation-based approach. For a
given projection angle, the 3D activity estimate is resampled using bilinear interpolation so
that planes are parallel to the detector. Each plane parallel to the detector is then convolved
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with the 2-dimensional CDR appropriate for that distance. Because the CDR has large tails
resulting from septal penetration, the convolution is performed in the frequency domain to
improve efficiency. The Fourier transforms of the CDR for a given distance are stored when
they are first computed. This transformed CDR is used for any subsequent convolutions
requiring the CDR for that distance.
Activity Calibration
Activity is quantitated by multiplying the attenuation- and scatter-corrected images by the
system sensitivity in air (cps/MBq), valid for narrow-beam geometry. The value for the
sensitivity has been obtained from both experimental measurements and Monte Carlo
simulations. Because of the practical difficulties involved in achieving narrow-beam geometry,
sensitivity measurements are performed on planar images for sources of varying area, from
which the sensitivity for an infinitesimal area is extrapolated (8). This experimentally obtained
value is compared with the sensitivity obtained from simulation of a point source in a scatter-
and attenuation-free environment, and without septal penetration. The source–detector distance
here is 10 cm, and the sum of the counts in the whole field of view is used.
Absorbed Dose Calculation
The absorbed dose is calculated on an individual patient basis using the activity map from the
quantitative SPECT image in combination with the anatomic information from the registered
CT scan. The absorbed dose is calculated by a Monte Carlo–based program, named DOSIMG
(dose images) (16), which determines the absorbed dose imparted by the activity distribution.
The program is based on the EGS4 software and the parameter-reduced electron-step transport
algorithm (17). EGS4 requires definition of the physical characteristics of the incident particles
and the target regions in which particle transport will be simulated. One parameter concerns
the energy cutoff values below which the transport of electrons and photons is terminated.
Another determines the maximum percentage of energy loss per transport step caused by
continuous slowing of electrons between hard collisions or radiative energy loss events. The
position of the decay is sampled from the activity images. The type of the emitted particle and
its initial kinetic energy are sampled according to the decay scheme of the radionuclide. To
consider the continuous electron energy distribution of an emitted β-particle, the energy
spectrum is calculated using the formula by Fermi. The energy of a particular β-particle is then
sampled from a probability distribution of this calculated energy spectrum. In EGS4, every
geometry region is defined with a different density and composition. Because the number of
regions can be large, a random voxel location is determined by first sampling a slice of voxels,
then sampling a row of voxels within the slice, and finally sampling a specific voxel within
that row. The actual decay point (x,y,z) is sampled uniformly within the selected voxel. The
energy deposition in each voxel is scored and normalized by the voxel mass to obtain the
absorbed dose in the voxel volume.
Evaluation
The evaluation is based on simulated images of an anthropomorphic phantom. For modeling
of the human body, the voxel-based phantom developed by Zubal and Harrell (18) is used,
which includes adult male anatomic structures obtained by segmentation of a CT scan. Each
of the phantom voxels has a logical value that associates it with an anatomic structure. Using
that information, a mass density distribution is generated from tabulated values (19) and is
applied to mimic the density map that, in clinical situations, is obtained from the CT study
(20). An activity distribution is also created, which in the current study was defined to mimic
a 131I radioimmunotherapy activity distribution (21). One hundred twenty-eight images,
ranging from slices 70–197 in the phantom, are used. The voxel size of the phantom is set to
0.34 cm in all dimensions, which then corresponds to a patient of 170-cm length.
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Table 1 and Figure 1A show the defined distribution of activity and activity concentration for
the major organs, the bone structures, and remaining tissues. Only a fraction of the bladder is
included in the subset of phantom slices, and the volume of the bladder therefore does not equal
a real bladder volume. Activity and density distributions are generated that resemble those of
a real patient and that are exactly matched spatially.
Monte Carlo simulation of SPECT images is performed using the SIMIND code (15), which
reads the voxel-based computer phantom together with the tabulated information about the
activity concentration in each organ. Decays are sampled according to the concentrations and
to the relative position of the voxel in the 3D phantom image array. For this study, SPECT
projections of 128 × 128 matrixes are generated over 64 projections and 360° rotations. The
pixel size is 0.34 cm. The simulated imaging system mimics a DIACAM scintillation camera
(Siemens Gammasonics, Inc., Hoffman Estates, IL) including a NaI(Tl) crystal of 9.35-mm
thickness and a high-energy hexagonal-hole collimator with flatto-flat distance of 0.406 cm,
septal thickness of 0.2 cm, and hole length of 5.97 cm. The energy resolution in the simulation
is set to 10.6% at 140 keV with a square root dependence on energy. An intrinsic spatial
resolution of 4.6 mm (FWHM) is used. SIMIND is linked to a special routine that allows for
simulation of photon interactions in the collimator septa (22). Simulation of 131I using this
routine was validated earlier by experimental measurement (3). A complete 131I photon decay
scheme is simulated. Two energy windows are defined—a photopeak window of 20% centered
at 364 keV (Fig. 1C) and a second scatter window, defined between 32 and 132 keV, which is
used to collect data for the SPECT–CT registration program (Fig. 1D). SPECT projections for
the ideal case in which no photon interactions are allowed in the phantom are also simulated
(Fig. 1B). These simulations are denoted as “air” in the Results. Generally, SIMIND normalizes
the count level in projection data to correspond to an activity of 1 MBq in the whole phantom
exposed to the camera in 1 s. For this study, the total activity in the phantom is redefined to 1
GBq. All simulations were performed using the parallel version of the SIMIND code (23) on
an SP2 distributed memory computer (International Business Machines Corp., Armonk, NY)
using the message passing instructions standard. Thirty-two nodes are used to produce the
projection data. No backscatter from compartments behind the crystal is simulated because
this effect is not included in the compensation model. Four subsets and 4 iterations are used in
the reconstruction. All reconstructed images are corrected for both septal penetration and
geometric collimator response. The reconstructed voxels are cubic in shape, with each side
equal to 0.34 cm.
To mimic the use of different setup parameters at the SPECT and CT acquisitions, a separate
density image is generated from the phantom of Zubal and Harrell (18), with axial extension
and voxel dimensions differing from those of the SPECT study. For modeling of patient
movements between the scans, the CT image is spatially transformed in relation to the SPECT
image by application of randomly chosen rotation and translations. For this study, 3
independent test images, denoted maps 1–3, are used for evaluation of the impact of the
registration (Fig. 2). The registered CT images are used as input to the quantification scheme.
For comparison, quantification is also performed using the original, perfectly matched CT–
SPECT couple, denoted map 0.
On the basis of the predefined activity and density maps (Table 1 and map 0), an absorbed dose
distribution is calculated to serve as the gold standard for the evaluation. This computation
applies the dose calculation program to the defined activity distribution and uses organ masses
derived from the voxel dimensions and the mass density of each organ. The cutoff energies for
the EGS4 program are defined to 200 and 10 keV for electrons and photons, respectively, and
150 million histories are simulated for each image dataset. The electrons are simulated down
to the cutoff energy even if their ranges are small compared with the voxel size. To simplify
the calculation of the absorbed dose, only 1 specific time point is simulated, for which the
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absorbed dose in each organ is calculated by assuming an effective half-time equal to the
physical decay of 131I, without considering any redistribution of the activity.
A summary of the evaluation procedure is presented in Figure 3, in which the SPECT-based
distributions of activity and absorbed dose are compared with the known distributions of
activity and the gold standard absorbed dose distributions.
RESULTS
The experimental value of the sensitivity was obtained to 24.3 ± 0.5 cps/MBq, and the simulated
value to 24.1 cps/MBq. Because of the good agreement, the simulated value was considered
verified and was further used for calculation of the activity.
The bottom row in Table 2 shows the total activity within the phantom, calculated by summing
the activity values in all voxels. An accurate value of the total activity is important because the
voxel distribution of the absorbed dose from the DOSIMG program is output in units of the
total activity in the whole phantom. The total activity was within 10% of the known value for
all cases. When comparing the activity value determined from the air simulation and the activity
values obtained when the ESSE correction is used in combination with the different attenuation
maps (maps 0–3) with the true activity value, the deviations are comparable, indicating that
the obtained overestimate was not caused by improper scatter and attenuation correction but
was primarily a result of limitations in the CDR correction. Using the 3 registered test images,
the total activity fluctuated slightly. This fluctuation was believed to be caused primarily by
the oblique section surfaces that result at registration for the top- and bottommost regions of
the CT (density) image.
Table 2 also shows the resulting organ average activity concentration (kBq/cm3) and the related
SD in the voxel activity values relative to the average value for the different cases. These results
were calculated using known VOIs obtained from the definition of the structures in the
anthropomorphic voxel phantom. For the major organs, the activity concentration, taking into
account the SD, was close to the known activity concentration. However, pancreas was
significantly overestimated both for the air case and for maps 0–3. The average activity
concentration of the bone marrow for maps 0–3 was close to the known value, but for the air
case the value was smaller. Using the 3 registered test images, the activity in all organs was
close to that obtained when the perfectly matched attenuation map, map 0, was used. The
registration method thus corrected well for the mimicked patient movements.
Figure 4 shows 2 transversal 2-dimensional absorbed dose distributions obtained for positions
that match the lung/heart and the liver region. The lung positions show that, despite the
collimator response correction, the blood compartments of the heart were difficult to
distinguish. An increased absorbed dose that was seen at the lung boundary but could not be
seen in the gold standard was an effect of the spatial resolution of the SPECT images, which
imposed a spread of the counts into the lung region, resulting in larger absorbed dose values
because of the low value of mass density. This factor explains the relatively large SD for the
dose absorbed by the lungs. The absorbed dose near the boundaries was less sharp for the 3
test cases (maps 1–3) than for the air and map 0 cases because of the interpolation involved in
the registration and the resulting smoothing of the density map. For the liver position, the air
and maps 0–3 cases look similar. A hot spot that was seen anterior to the right kidney but could
barely be seen in the gold standard image was caused by the blurring of counts into a gas pocket
present in the bowel, which had a low mass density and therefore produced high absorbed dose
values. This pocket can also be seen in a density map in Figure 2. Table 3 shows the average
absorbed dose per voxel with the VOI and the related SD.
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The time to generate the SPECT projection data on the SP2 parallel computer was on the order
of 1.5 d. Reconstruction and absorbed dose calculations were done on a computer with a 1,400-
MHz AMD Athlon processor (Advanced Micro Devices, Inc., Sunnyvale, CA) and a Linux
operation system. The computing time for the activity quantification and absorbed dose
calculation was approximately 3.5 and 1 h, respectively. The time to register an image was on
the order of 0.5 h.
DISCUSSION
The results of this study have shown that it is possible to compensate for the physical limitations
in SPECT images by applying iterative reconstruction including correction for scatter,
attenuation, collimator response, and septal penetration. The resulting images can therefore be
converted to activity images using a single calibration factor, because the sensitivity for
parallel-hole collimators is independent of the source location relative to the camera for the
case of no septal penetration.
Agreement was good between results obtained for the 3 registered attenuation maps and the
known activity or gold standard absorbed dose distribution (Tables 2 and 3). This good
agreement shows that the mutual information-based 3D registration method is accurate and
compensates well for the mimicked patient movements. In this study, only rigid patient
movements were modeled; elastic transformations, such as trunk twisting, were not included.
The possibility of determining a more complex spatial transformation is believed to be limited
because of the limited resolution of the gamma camera system and the generally poor quality
of SPECT images.
Recently, combined CT–SPECT acquisition systems have been developed that yield
intrinsically matched CT and SPECT studies (24). For those systems, image registration may
prove to be obsolete. However, most contemporary systems still work in single mode and
require registration of SPECT and CT images.
The activity and absorbed dose have been evaluated for the known volumes of the phantom of
Zubal and Harrell (18). This process corresponds to a derivation of volumes or masses from
CT images. Because of the limited spatial resolution of SPECT, the number of counts and
hence the measured activity is underestimated, or overestimated, depending on the relative
significance of spill-out and spill-in. Even if collimator response correction is applied, an ideal
resolution clearly is not recovered, implying that the partial-volume effect limits activity
quantification. Two additional simulations were conducted to investigate the magnitude of the
partial-volume effect. For the first simulation, activity was defined within the liver only; for
the second, activity was assigned to the myocardium only. Quantification and evaluation were
then performed and revealed that only 69% and 51% of the known activities were obtained for
the liver and the myocardium, respectively. However, a review of Table 2 shows that the
activity is overestimated in both the liver and the heart. The region defining the heart in the
phantom of Zubal and Harrell is limited to the myocardial muscle, whereas the blood in the
left and right ventricles is defined by a different code (i.e., the blood is a different VOI). For
the activity distribution used (Table 1), the activity concentration of the blood pool is high in
comparison with the myocardium, and the overestimate of activity is caused by spill-in from
the blood region. For the liver case, the high activity of the right kidney similarly contributes
to the liver activity. To reduce the partial-volume effect, the spatial resolution of the imaging
systems needs improvement. For high-count-rate cases, such as in therapy imaging, the spatial
resolution can be improved using long-bore collimators. New SPECT systems with thicker
crystals will increase the sensitivity for high-energy photon imaging, which may reduce the
need for image processing such as low-pass filtering. In addition, improvement in the accuracy
of the collimator response correction is possible. A related factor that deserves attention is
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correction for motion caused by respiration. The phantom used in this study does not include
this effect, but breathing generally imposes a blurring effect, especially in the upper thorax.
The absorbed dose calculated in this study does not include temporal activity variations within
the organs and redistribution. The absorbed dose has been calculated using physical decay
only. An additional error caused by the fitting of the time–activity curve to the voxel values
can here be expected. A Monte Carlo study of a full patient procedure including simulations
of redistribution over time is, however, beyond the scope of this article.
The results from the absorbed dose program are stored as 3D images with the same voxel size
as the input images. Additional software can be used to present the absorbed dose calculations
in selected VOIs as dose volume histograms or isocontour images. Dose volume histograms
can then be useful to determine, for example, the maximum absorbed dose within a VOI. It
must also be remembered that the voxel size in the SPECT images is less than the spatial
resolution of the system, and the large values for SD, presented in Tables 2 and 3, can be caused
by this difference.
The use of SPECT images as a basis for absorbed dose calculations adds a source of error,
because the activity distribution shown is not a true distribution but a distribution blurred by
the spatial resolution of the SPECT system. It is therefore possible that the current methodology
overestimates the spatial spread of energy from the β-particles. For comparison, the absorbed
dose was calculated for a complete absorption of energy from electrons and β-particles and the
theoretic decay scheme of 131I. The absorbed dose from electrons and β-particles to the kidneys,
lungs, stomach, spleen, liver, heart, and bone marrow was calculated to be 9.7, 2.0, 0.5, 5.8,
4.8, 2.4, and 2.5 Gy, respectively. These values agree with the absorbed dose values from the
DOSIMG program (Table 3), implying that most of the electron energy is locally absorbed
within the voxels from which they are emitted. For radionuclides that emit β-particles of higher
energies than 131I, such as 90Y, the kinetic energy of the particle is not likely to be completely
absorbed within a voxel. The absorbed dose calculation possibly will still gain if the electron
energy is treated as locally absorbed, to partly compensate for the blurring effect of the
scintillation camera on the activity images. However, further investigations are required on
this matter. Especially, it is of interest to determine when (i.e., for which radionuclides) an
explicit ray tracing of the electron path is required.
RNT using radiopharmaceuticals such as monoclonal antibodies and hormone analogues,
which can target specific tumors, is becoming established in cancer treatment. Accurate
dosimetry is required both for dose planning and for radiobiologic evaluation. Several
procedures for 3D absorbed dose calculations have been suggested on the basis of dose point
kernels (25,26), voxel S-factors (27), and Monte Carlo simulations (5–7). The absorbed dose
distributions obtained by such procedures may be evaluated and verified using experimental
dosimeter measurements or computer modeling. A limitation for experimental measurements
is the relatively limited geometries that can be applied. For example, one of the patientlike
anthropomorphic phantoms commercially available includes a realistic skeleton embedded in
a tissue-equivalent material and compartments corresponding to the lungs, the heart, the liver,
and a remaining background. The possibility of mimicking a more detailed patientlike activity
distribution, such as the one in this study, is thus limited using such a phantom. Furthermore,
the variation in the placement of dosimeters is determined by the physical construction of the
phantom, which makes the absorbed dose distribution difficult to resolve in detail. Using an
accurate Monte Carlo program in combination with a voxel-based phantom overcomes these
limitations and therefore adds flexibility in the evaluation of sources of error in quantification
methodology. The presented evaluation methodology thus offers an alternative to experimental
measurements for use in quality control and in the evaluation of procedures for calculating
absorbed dose in RNT dosimetry. The evaluation methodology also makes possible the
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investigation of how overall accuracy is affected by the various steps involved in calculating
absorbed dose.
CONCLUSION
We have found that use of an ordered-subsets maximization expectation reconstruction
program that corrects for physical limitations, in combination with an accurate image
registration program and a 3D absorbed dose calculation program, can produce accurate
activity and absorbed dose distributions for a complicated decay, such as that of 131I. We have
also shown that Monte Carlo evaluation is a powerful tool for evaluation of the different steps
in the dosimetry calculation chain.
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(A) Planar projection of defined activity distribution. (B) Monte Carlo simulated projection
image of 131I of same activity distribution in air, that is, including only deterioration caused
by collimator response and septal penetration. (C) Projection image obtained when including
attenuation and scatter, which thus simulates real patient situation. (D) Projection image
obtained for 32- to 132-keV scatter energy window, used for image registration procedure.
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Mass density images used to mimic CT-derived mass density map for quantification. Maps 1–
3 show transversal, coronal, and sagittal slices for the 3 test cases, before and after registration
to SPECT image.
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Flow chart describing methodology of quantification procedure and evaluation. Known activity
map and gold standard absorbed dose distribution are compared with corresponding maps
obtained from quantitative SPECT calculation scheme.
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Transversal section of absorbed dose distribution for slice through lungs (top row) and liver
(bottom row) for different cases. Images were all normalized to same gray level.
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TABLE 1
The Defined Activity and Activity Concentration for Major Organs
Organ kBq/cm3 Volume (cm3) MBq in VOI
Bladder 67 55 3.7
Blood pool 267 528 141.1
Bone marrow 83 445 37.1
Heart 83 368 30.7
Kidney 334 299 100.0
Liver 167 1,151 192.1
Lung 17 2,413 40.3
Pelvis 100 333 33.4
Spleen 200 219 43.8
Urine 167 120 20.0
Bone structures 50 1,187 59.4
Remaining tissues 17 19,917 332.6
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